Karuna Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION

Last updated:

Abstract:

Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.

Status:
Application
Type:

Utility

Filling date:

3 Feb 2022

Issue date:

19 May 2022